Development of a polycaprolactone/poly(p-dioxanone) bioresorbable stent with mechanically self-reinforced structure for congenital heart disease treatment [PDF]
Bioactive Materials, 2021 Recent progress in bioresorbable stents (BRSs) has provided a promising alternative for treating coronary artery disease. However, there is still lack of BRSs with satisfied compression and degradation performance for pediatric patients with congenital ...
Fan Zhao, Jing Sun, Wen Xue
exaly +4 more sources
Five-Year Outcomes of Bioresorbable Stent Therapy for Coronary Heart Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials [PDF]
Reviews in Cardiovascular MedicineBackground: The efficacy of bioresorbable vascular scaffolds (BVS) compared to metallic stents for the treatment of coronary heart disease remains controversial.
Fei-fei Yang +6 more
doaj +2 more sources
A novel tissue-engineered stent graft combining decellularized scaffold and bioresorbable stent: a pilot feasibility study in a porcine model [PDF]
OrganogenesisEndovascular aneurysm repair (EVAR) is a widely accepted treatment for aortic pathologies owing to its minimally invasive nature. However, long-term complications, such as stent graft migration and infection, remain unresolved, primarily due to the ...
Tatsuya Shimogawara +6 more
doaj +2 more sources
Integrating stent design and microstructural characterization to improve clinical outcomes of bioresorbable stents [PDF]
Materials & DesignBioresorbable stents were conceived to revolutionize the treatment of cardiovascular diseases. However, their significant benefits were overshadowed by a higher clotting rate compared to permanent implants.
Francesc Canalejo-Codina +5 more
doaj +2 more sources
Stent Thrombosis: A Narrative Review From Pathophysiology to Therapy. [PDF]
Clin CardiolStent thrombosis remains a life‐threatening complication of PCI driven by complex interactions between stent design, procedural factors, thrombogenic milieu, and inflammation. This review integrates pathophysiological mechanisms with contemporary and emerging therapeutic strategies, highlighting optimized PCI, tailored antithrombotic therapy, and novel
Cecchi E +8 more
europepmc +2 more sources
Preclinical research models for evaluating the biocompatibility of bioresorbable metallic cardiovascular stents: A comparative review [PDF]
Bioactive MaterialsCardiovascular stents are widely used to treat atherosclerosis by relieving vascular obstruction and providing structural support after coronary angioplasty.
Samuel Hansen +3 more
doaj +2 more sources
PLoS ONE, 2022 PurposeCoronary bioresorbable stents (BRS) do not produce blooming artifacts on computed tomography (CT), in contrast to metallic stents, as they are made of a bioresorbable polymer and are radiolucent. They allow to evaluate the coronary plaque beneath.
Evguenia Zdanovich +6 more
doaj +2 more sources
Update on coronary artery bioresorbable vascular scaffolds in percutaneous coronary revascularization [PDF]
Reviews in Cardiovascular Medicine, 2021 Coronary angioplasty was first introduced in 1977. From plain old balloon angioplasty to the introduction of bare metal stents in 1986 and dual antiplatelet therapy in 1992 to much more later on.
Nagi Azzi +1 more
doaj +1 more source
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2021 Background Percutaneous coronary intervention of calcified lesions was associated with worse outcomes in the era of bare‐metal and first‐generation drug‐eluting stents. Data on percutaneous coronary intervention of calcified lesions with newer‐generation
Rayyan Hemetsberger +13 more
doaj +1 more source
In vivo degradation and endothelialization of an iron bioresorbable scaffold
Bioactive Materials, 2021 Detection of in vivo biodegradation is critical for development of next-generation medical devices such as bioresorbable stents or scaffolds (BRSs). In particular, it is urgent to establish a nondestructive approach to examine in vivo degradation of a ...
Wenjiao Lin +15 more
doaj +1 more source